行情

MNK

MNK

马林克罗制药
NYSE

实时行情|Nasdaq Last Sale

5.20
-0.04
-0.76%
盘后: 5.19 -0.01 -0.19% 18:48 01/17 EST
开盘
5.18
昨收
5.24
最高
5.33
最低
4.910
成交量
1,163.27万
成交额
--
52周最高
27.33
52周最低
1.430
市值
4.37亿
市盈率(TTM)
-0.1216
分时
5日
1月
3月
1年
5年

分析师评级

13位分析师的综合评级

中性

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

MNK 新闻

  • Should Value Investors Consider Mallinckrodt (MNK) Stock?
  • Zacks.13小时前
  • J&J's $8B Jury Award in Risperdal Case Cut to $6.8M by Judge
  • Zacks.14小时前
  • 3 Big Winners From the "Super Bowl of Healthcare"
  • MotleyFool.com.1天前
  • Why Mallinckrodt Stock Is Jumping Today
  • MotleyFool.com.4天前

更多

所属板块

制药
+0.13%
制药与医学研究
+0.06%

热门股票

名称
价格
涨跌幅

MNK 简况

Mallinckrodt public limited company develops, manufactures, markets and distributes branded and generic specialty pharmaceutical products and therapies. The Company focuses on various therapeutic areas, such as autoimmune and rare disease specialty areas, including neurology, rheumatology, nephrology, ophthalmology and pulmonology; immunotherapy and neonatal critical care respiratory therapies; analgesics and hemostasis products, and central nervous system drugs. Its segments include Specialty Brands and Specialty Generics. The Specialty Brands segment produces and markets branded pharmaceutical products and therapies. The Specialty Generics segment produces and markets specialty generic pharmaceuticals and active pharmaceutical ingredient (API) consisting of biologics, medicinal opioids, synthetic controlled substances, acetaminophen and other active ingredients. Its product portfolio includes Acthar, Inomax, Ofirmev, Therakos immunotherapy, Hemostasis products and StrataGraft.
展开

Webull提供Mallinckrodt PLC的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。